John Henneman

Mr. John B. Henneman, III, is an Independent Director at Orthofix Medical, Inc., a Lead Independent Director at Anika Therapeutics, Inc. and a Lead Independent Director at Aprea Therapeutics, Inc. He is on the Board of Directors at Orthofix Medical, Inc., Anika Therapeutics, Inc., Aprea Therapeutics AB, Aprea Therapeutics, Inc. and Alafair Biosciences, Inc. Mr. Henneman was previously employed as a Lead Independent Director by R1 RCM, Inc., an Independent Director by SeaSpine Holdings Corp., a Chief Financial Officer, Secretary & Executive VP by NewLink Genetics Corp., a Chief Financial Officer by Integra LifeSciences Holdings Corp., an Interim Co-Chief Executive Officer & Secretary by Neuromedical Systems, Inc., and a Chairman by New Deal Technology SAS. He received his undergraduate degree from Princeton University and a graduate degree from The University of Michigan Law School.